501 related articles for article (PubMed ID: 27764715)
1. Understanding mechanisms of autoimmunity through translational research in vitiligo.
Strassner JP; Harris JE
Curr Opin Immunol; 2016 Dec; 43():81-88. PubMed ID: 27764715
[TBL] [Abstract][Full Text] [Related]
2. Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo.
Tulic MK; Cavazza E; Cheli Y; Jacquel A; Luci C; Cardot-Leccia N; Hadhiri-Bzioueche H; Abbe P; Gesson M; Sormani L; Regazzetti C; Beranger GE; Lereverend C; Pons C; Khemis A; Ballotti R; Bertolotto C; Rocchi S; Passeron T
Nat Commun; 2019 May; 10(1):2178. PubMed ID: 31097717
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM
J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo.
Agarwal P; Rashighi M; Essien KI; Richmond JM; Randall L; Pazoki-Toroudi H; Hunter CA; Harris JE
J Invest Dermatol; 2015 Apr; 135(4):1080-1088. PubMed ID: 25521459
[TBL] [Abstract][Full Text] [Related]
5. A Concise Review on the Role of Endoplasmic Reticulum Stress in the Development of Autoimmunity in Vitiligo Pathogenesis.
Jadeja SD; Mayatra JM; Vaishnav J; Shukla N; Begum R
Front Immunol; 2020; 11():624566. PubMed ID: 33613564
[TBL] [Abstract][Full Text] [Related]
6. Translational Research in Vitiligo.
Katz EL; Harris JE
Front Immunol; 2021; 12():624517. PubMed ID: 33737930
[TBL] [Abstract][Full Text] [Related]
7. Vitiligo: Mechanistic insights lead to novel treatments.
Frisoli ML; Harris JE
J Allergy Clin Immunol; 2017 Sep; 140(3):654-662. PubMed ID: 28778794
[TBL] [Abstract][Full Text] [Related]
8. Anatomically distinct fibroblast subsets determine skin autoimmune patterns.
Xu Z; Chen D; Hu Y; Jiang K; Huang H; Du Y; Wu W; Wang J; Sui J; Wang W; Zhang L; Li S; Li C; Yang Y; Chang J; Chen T
Nature; 2022 Jan; 601(7891):118-124. PubMed ID: 34912121
[TBL] [Abstract][Full Text] [Related]
9. Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo.
Harris JE
Immunol Rev; 2016 Jan; 269(1):11-25. PubMed ID: 26683142
[TBL] [Abstract][Full Text] [Related]
10. Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity.
Lin X; Tian H; Xianmin M
Med Hypotheses; 2011 Mar; 76(3):339-42. PubMed ID: 21075543
[TBL] [Abstract][Full Text] [Related]
11. Evidence for an autoimmune pathogenesis of vitiligo.
Ongenae K; Van Geel N; Naeyaert JM
Pigment Cell Res; 2003 Apr; 16(2):90-100. PubMed ID: 12622785
[TBL] [Abstract][Full Text] [Related]
12. Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease.
Richmond JM; Bangari DS; Essien KI; Currimbhoy SD; Groom JR; Pandya AG; Youd ME; Luster AD; Harris JE
J Invest Dermatol; 2017 Feb; 137(2):350-358. PubMed ID: 27686391
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-3940-5p promotes T-cell activity by targeting the cytokine receptor IL-2R gamma on human cutaneous T-cell lines.
Wang Y; Wang K; Dang N; Wang L; Zhang M
Immunobiology; 2016 Dec; 221(12):1378-1381. PubMed ID: 27502164
[TBL] [Abstract][Full Text] [Related]
14. Targeting the PD-1/PD-L1 Axis in Human Vitiligo.
Willemsen M; Melief CJM; Bekkenk MW; Luiten RM
Front Immunol; 2020; 11():579022. PubMed ID: 33240267
[TBL] [Abstract][Full Text] [Related]
15. Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?
Garbelli S; Mantovani S; Palermo B; Giachino C
Pigment Cell Res; 2005 Aug; 18(4):234-42. PubMed ID: 16029417
[TBL] [Abstract][Full Text] [Related]
16. A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo.
Das PK; van den Wijngaard RM; Wankowicz-Kalinska A; Le Poole IC
Trends Immunol; 2001 Mar; 22(3):130-6. PubMed ID: 11286727
[TBL] [Abstract][Full Text] [Related]
17. Cytokines: the yin and yang of vitiligo pathogenesis.
Singh M; Kotnis A; Jadeja SD; Mondal A; Mansuri MS; Begum R
Expert Rev Clin Immunol; 2019 Feb; 15(2):177-188. PubMed ID: 30462555
[TBL] [Abstract][Full Text] [Related]
18. Autoimmunity as an aetiological factor in vitiligo.
Rezaei N; Gavalas NG; Weetman AP; Kemp EH
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):865-76. PubMed ID: 17658994
[TBL] [Abstract][Full Text] [Related]
19. Mutant HSP70 reverses autoimmune depigmentation in vitiligo.
Mosenson JA; Zloza A; Nieland JD; Garrett-Mayer E; Eby JM; Huelsmann EJ; Kumar P; Denman CJ; Lacek AT; Kohlhapp FJ; Alamiri A; Hughes T; Bines SD; Kaufman HL; Overbeck A; Mehrotra S; Hernandez C; Nishimura MI; Guevara-Patino JA; Le Poole IC
Sci Transl Med; 2013 Feb; 5(174):174ra28. PubMed ID: 23447019
[TBL] [Abstract][Full Text] [Related]
20. The Role of the NKG2D in Vitiligo.
Plaza-Rojas L; Guevara-Patiño JA
Front Immunol; 2021; 12():624131. PubMed ID: 33717132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
